U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.
Perrigo CEO Joe Papa discusses the biotech industry, the state of the consumer and why Mucinex is going to be a big winner for his company.
ALLEGAN, Mich.-- Perrigo Co., which makes store-brand over-the-counter drugs and infant formulas, said Wednesday that it received approval from the U.S. Food and Drug Administration to market an over-the-counter nicotine product similar to Nicorette mini lozenges.
*Receives FDA approval to market mini nicotine lozenges.
You’ve heard about all those big stocks that you should buy, but the pros say there are plenty of mid-size names that belong on your radar too.
Perrigo CEO Joseph Papa appeared on Wednesday's "Mad Money."
A lot of people aren’t doing their homework and those people are losing money.
Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.
The “Mad Money” host explains why Europe’s problems trump good news out of the US.